The oncology landscape has rapidly shifted toward oral oncolytics, targeted therapies, and hormone maintenance treatments taken at home. However, global studies indicate that up to 40% of cancer patients fail to maintain prescribed adherence, leading to disease progression, preventable toxicities, and premature drug discontinuation. OncoCare’s dedicated cancer treatment adherence platform solves this challenge through an intelligent, empathetic closed-loop system. By blending scheduled reminders, smart pill logging, automated toxicity feedback, and direct clinical intervention triggers, OncoCare ensures patients stay on track with their life-saving regimens while keeping medical oncologists informed of real-world compliance. Integrated with hospital daycare pharmacies and regional delivery networks, the system guarantees that medication barriers—from high drug costs to overwhelming pill counts—are identified and mitigated before they derail clinical outcomes.
Engineered for Oncology Precision
Advanced capabilities tailored for high-volume cancer care delivery
Cycle-Aware Medication Scheduling
Built to handle complex cyclical oncology schedules (e.g., 21 days on, 7 days off; alternating weekly doses; tapering corticosteroid regimens).
Smart Pill Verification & Intake Logs
Effortless one-tap logging with camera-assisted blister confirmation and timestamp tracking to prevent both missed doses and accidental toxic double-dosing.
Toxicity-Triggered Dose Holding
If a patient reports Grade 2+ mucositis, diarrhea, or rash, the platform provides immediate safety holding guidance while alerting the prescribing oncologist.
Caregiver Adherence Mirroring
Designated family caregivers receive SMS or WhatsApp notifications if a critical morning or evening oncology dose remains unlogged after a 45-minute buffer.
Refill & Daycare Cycle Forecasting
Tracks remaining pill inventory and automatically prompts patients 5 days before stock depletion, coordinating pharmacy delivery or hospital prescription refills.
Comprehensive Adherence Reports
Generates exportable compliance graphs and percentage scores (Medication Possession Ratio / PDC) ready for review during clinic consultations.
Tailored for Every Oncology Stakeholder
Bridging communication, clinical safety, and care coordination
🏥 For Cancer Hospitals
Elevates therapeutic persistence rates across oral targeted therapy programs, strengthens pharmacy dispensing revenues, and secures superior clinical accreditation metrics.
🩺 For Oncologists
Eliminates patient recall bias; oncologists can instantly determine whether an unexpected lack of response is due to biological drug resistance or sub-optimal pill adherence.
🤝 For Patients & Caregivers
Patients gain clarity and peace of mind over daunting multi-drug regimens, reducing anxious medication errors and dangerous treatment interruptions.
Frequently Asked Questions
Essential guidance for healthcare executives, clinicians, and patients
IV chemotherapy is directly administered and monitored by oncology nurses in the daycare unit. In contrast, oral chemotherapy places the entire responsibility of timing, dietary restrictions, and managing debilitating adverse effects onto the patient and family at home.
OncoCare provides drug-specific guidance vetted by medical oncologists—advising whether to take the dose within a specific hour window or skip it until the next scheduled time, strictly avoiding hazardous double-dosing.
The platform tracks anti-emetics (e.g., Ondansetron, Aprepitant), gastric protectors, pain medications, and prophylactic antibiotics alongside primary oncolytics to ensure complete supportive coverage.
Yes, hospital administrators and department heads have access to an analytics dashboard showing aggregate adherence rates, dropout patterns, and drug toxicity profiles across tumor types.